CBPO [China Biologic Products] 10-Q: FORM 10–Q (Mark One) For the quarterly period

[FORM 10–Q (Mark One) For the quarterly period ended: March 31, 2012 [ ] For the transition period from ____________to _____________ CHINA BIOLOGIC PRODUCTS, INC. Delaware 75-2308816 (State or other jurisdiction of (I.R.S. Employer Identification No.) incorporation or organization) 18th Floor, Jialong International Building Chaoyang District, Beijing 100125 (+86) 10-6598-3111 _____________________________________________________________________ (Former name, former address and former fiscal year, if] [CERTIFICATIONS I, Chao Ming Zhao, certify that: 1. I have reviewed this quarterly report on Form 10-Q of China Biologic Products, Inc.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such] [CERTIFICATIONS I, Y. Tristan Kuo, certify that: 1. I have reviewed this quarterly report on Form 10-Q of China Biologic Products, Inc.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such] [2. Information contained in the Report fairly presents, in all material respects, the financial condition and results of operation of the Company. th] [2. Information contained in the Report fairly presents, in all material respects, the financial condition and results of operation of the Company. th (Principal Financial Officer)]

CBPO [China Biologic Products] DEF 14A: SCHEDULE 14A Check the appropriate box: [ ]

[SCHEDULE 14A Check the appropriate box: [ ] Preliminary Proxy Statement [ ] [X] Definitive Proxy Statement [ ] Definitive Additional Materials [ ] Soliciting Material under Rule 14a-12 CHINA BIOLOGIC PRODUCTS, INC. ____________________________________________________________ Payment of Filing Fee (Check the appropriate box): [X] No fee required [ ] Fee computed on table below per Exchange Act Rules 14a-6(i)(1) and 0-11.]

CBPO [China Biologic Products] DEFA14A: (Original Filing)

[SCHEDULE 14A Check the appropriate box: [ ] Preliminary Proxy Statement [ ] [ ] Definitive Proxy Statement [X] Definitive Additional Materials [ ] Soliciting Material under Rule 14a-12 CHINA BIOLOGIC PRODUCTS, INC. ____________________________________________________________ Payment of Filing Fee (Check the appropriate box): [X] No fee required [ ] Fee computed on table below per Exchange Act Rules 14a-6(i)(1) and 0-11.]

CBPO [China Biologic Products] DEFA14A: SCHEDULE 14A Check the appropriate box: [ ]

[SCHEDULE 14A Check the appropriate box: [ ] Preliminary Proxy Statement [ ] [ ] Definitive Proxy Statement [X] Definitive Additional Materials [ ] Soliciting Material under Rule 14a-12 CHINA BIOLOGIC PRODUCTS, INC. ____________________________________________________________ Payment of Filing Fee (Check the appropriate box): [X] No fee required [ ] Fee computed on table below per Exchange Act Rules 14a-6(i)(1) and 0-11.]

CBPO [China Biologic Products] 8-K: (Original Filing)

[China Biologic Has Announced the Resignation of CFO Y. Tristan Kuo and Named Mr. Ming Yang as Interim CFO BEIJING, China, April 27, 2012 /PRNewswire via COMTEX/ China Biologic Products, Inc. (NASDAQ: CBPO, “China Biologic” or the “Company”), one of the leading plasma-based biopharmaceutical companies in the People’s Republic of China, today announced the resignation of Chief Financial Officer, Mr.] [FORM 8-K CURRENT REPORT Date of Report (Date of Earliest event Reported): April 26, 2012 CHINA BIOLOGIC PRODUCTS, INC. Delaware 001-34566 75-2308816 (State or other jurisdiction of (Commission File No.) (IRS Employer ID No.) incorporation or organization) No. 14 East Hushan Road, Tai’an City, Shandong, 271000 People’s Republic of China 86-538 -620-2306 ____________________________________________________________ (Former name or former address, if changed]

CBPO [China Biologic Products] 8-K: China Biologic Has Announced the Resignation of CFO

[China Biologic Has Announced the Resignation of CFO Y. Tristan Kuo and Named Mr. Ming Yang as Interim CFO BEIJING, China, April 27, 2012 /PRNewswire via COMTEX/ China Biologic Products, Inc. (NASDAQ: CBPO, “China Biologic” or the “Company”), one of the leading plasma-based biopharmaceutical companies in the People’s Republic of China, today announced the resignation of Chief Financial Officer, Mr.] [FORM 8-K CURRENT REPORT Date of Report (Date of Earliest event Reported): April 26, 2012 CHINA BIOLOGIC PRODUCTS, INC. Delaware 001-34566 75-2308816 (State or other jurisdiction of (Commission File No.) (IRS Employer ID No.) incorporation or organization) No. 14 East Hushan Road, Tai’an City, Shandong, 271000 People’s Republic of China 86-538 -620-2306 ____________________________________________________________ (Former name or former address, if changed]

CBPO [China Biologic Products] 8-K: (Original Filing)

[China Biologic’s Board Has Appointed Two New Independent Directors to Boost Corporate Governance BEIJING, China, April 25, 2012 /PRNewswire/ China Biologic Products, Inc. (NASDAQ: CBPO, “China Biologic” or the “Company”), one of the leading plasma-based biopharmaceutical companies in the People’s Republic of China, today announced that effective April 20, 2012, the Company’s Board of Directors (the “Board”) has appointed Mr.] [FORM 8-K CURRENT REPORT Date of Report (Date of Earliest event Reported): April 20, 2012 CHINA BIOLOGIC PRODUCTS, INC. Delaware 001-34566 75-2308816 (State or other jurisdiction of (Commission File No.) (IRS Employer ID No.) incorporation or organization) No. 14 East Hushan Road, Tai’an City, Shandong, 271000 People’s Republic of China 86-538 -620-2306 (Former name or former address, if changed since]

CBPO [China Biologic Products] 8-K: China Biologic’s Board Has Appointed Two New Independent

[China Biologic’s Board Has Appointed Two New Independent Directors to Boost Corporate Governance BEIJING, China, April 25, 2012 /PRNewswire/ China Biologic Products, Inc. (NASDAQ: CBPO, “China Biologic” or the “Company”), one of the leading plasma-based biopharmaceutical companies in the People’s Republic of China, today announced that effective April 20, 2012, the Company’s Board of Directors (the “Board”) has appointed Mr.] [FORM 8-K CURRENT REPORT Date of Report (Date of Earliest event Reported): April 20, 2012 CHINA BIOLOGIC PRODUCTS, INC. Delaware 001-34566 75-2308816 (State or other jurisdiction of (Commission File No.) (IRS Employer ID No.) incorporation or organization) No. 14 East Hushan Road, Tai’an City, Shandong, 271000 People’s Republic of China 86-538 -620-2306 (Former name or former address, if changed since]

CBPO [China Biologic Products] 8-K: (Original Filing)

[Company Contact Mr. Ming Yin Vice President - Business Development China Biologic Products, Inc. Telephone: +86 10 6598 3099 Email: ir@chinabiologic.com www.chinabiologic.com China Biologic’s Board Has Elected David (Xiaoying) Gao as the New Chairman and Has Adopted a Series of Measures to Enhance China Biologic’s Corporate Governance BEIJING, April 2, 2012 /PRNewswire/ China Biologic Products, Inc. (NASDAQ: CBPO, “China Biologic”] [FORM 8-K CURRENT REPORT Date of Report (Date of Earliest event Reported): April 2, 2012 CHINA BIOLOGIC PRODUCTS, INC. Delaware 001-34566 75-2308816 (State or other jurisdiction of (Commission File No.) (IRS Employer ID No.) incorporation or organization) 18th Floor, Jialong International Building, 19 Chaoyang Park Road Chaoyang District, Beijing 100125 People’s Republic of China (+86) 10-6598-3111 (Former name or former]

CBPO [China Biologic Products] 8-K: Company Contact Mr. Ming Yin Vice President –

[Company Contact Mr. Ming Yin Vice President - Business Development China Biologic Products, Inc. Telephone: +86 10 6598 3099 Email: ir@chinabiologic.com www.chinabiologic.com China Biologic’s Board Has Elected David (Xiaoying) Gao as the New Chairman and Has Adopted a Series of Measures to Enhance China Biologic’s Corporate Governance BEIJING, April 2, 2012 /PRNewswire/ China Biologic Products, Inc. (NASDAQ: CBPO, “China Biologic”] [FORM 8-K CURRENT REPORT Date of Report (Date of Earliest event Reported): April 2, 2012 CHINA BIOLOGIC PRODUCTS, INC. Delaware 001-34566 75-2308816 (State or other jurisdiction of (Commission File No.) (IRS Employer ID No.) incorporation or organization) 18th Floor, Jialong International Building, 19 Chaoyang Park Road Chaoyang District, Beijing 100125 People’s Republic of China (+86) 10-6598-3111 (Former name or former]

Skip to toolbar